CAS 1402612-55-8

Methanone, (4-[1,1'-biphenyl]-4-yl-1H-1,2,3-triazol-1-yl)[2-(phenylMethyl)-1-piperidinyl]-

Description:

Methanone, specifically the compound with the name "Methanone, (4-[1,1'-biphenyl]-4-yl-1H-1,2,3-triazol-1-yl)[2-(phenylMethyl)-1-piperidinyl]-" and CAS number 1402612-55-8, is a complex organic molecule characterized by its unique structural features. It contains a methanone functional group, which is indicative of a ketone, and incorporates a triazole ring, known for its stability and biological activity. The presence of a biphenyl moiety suggests potential applications in materials science and pharmaceuticals due to its ability to enhance electronic properties. Additionally, the piperidine ring contributes to the compound's potential as a pharmacophore, which may interact with biological targets. The overall structure indicates a high degree of molecular complexity, which may influence its solubility, reactivity, and biological activity. Such compounds are often investigated for their potential therapeutic applications, particularly in areas such as cancer research or as antimicrobial agents, owing to the diverse functionalities provided by the various substituents in the molecule.

Formula: C₂₇H₂₆N₄O

Synonyms:

• KT-109
• Methanone, (4-[1,1'-biphenyl]-4-yl-1H-1,2,3-triazol-1-yl)[2-(phenylMethyl)-1-piperidinyl]-
• (2-benzylpiperidin-1-yl)-[4-(4-phenylphenyl)triazol-1-yl]methanone
• KT109 >=98% (HPLC)
• (KT109)

KT109

Controlled Product

CAS: 1402612-55-8

KT109 is a fatty acid that has been shown to be detected in the blood of heterozygous mice. It is also found in wild-type mice, but not at levels as high as those found in heterozygous mice. KT109 is associated with degenerative diseases such as Alzheimer's and Parkinson's disease, which may be due to its role in regulating the production of endocannabinoids. Endocannabinoids are neurotransmitters that act on cannabinoid receptors and have been shown to play a role in the treatment of these degenerative diseases.

Formula: C₂₇H₂₆N₄O

Purity: Min. 95%

Molecular weight: 422.52 g/mol

Ref: 3D-CGC61255

KT109

CAS: 1402612-55-8

KT109 is a DAGLβ inhibitor (IC50=42nM), lessens LPS allodynia in mice without tolerance, and has no major side effects.

Formula: C₂₇H₂₆N₄O

Purity: 98%

Color and Shape: Solid

Molecular weight: 422.52

Ref: TM-T27752